International Journal of Radiation Oncology*Biology*Physics

Where are the at-risk cervical nodes?
pp. 1-2(2)
Author: Garden A.S.

Is there a favorable subset of patients with prostate cancer who develop oligometastases?
pp. 3-10(8)
Authors: Singh D.; Yi W.S.; Brasacchio R.A.; Muhs A.G.; Smudzin T.; Williams J.P.; Messing E.; Okunieff P.

What defines intermediate-risk prostate cancer? Variability in published prognostic models
pp. 11-18(8)
Authors: Williams S.G.; Millar J.L.; Dally M.J.; Sia S.; Miles W.; Duchesne G.M.

Perineural invasion is associated with increased relapse after external beam radiotherapy for men with low-risk prostate cancer and may be a marker for occult, high-grade cancer
pp. 19-24(6)
Authors: Beard C.J.; Chen M.H.; Cote K.; Loffredo M.; Renshaw A.A.; Hurwitz M.; D'Amico A.V.

Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy >=72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer
pp. 25-33(9)
Authors: Kupelian P.A.; Potters L.; Khuntia D.; Ciezki J.P.; Reddy C.A.; Reuther A.M.; Carlson T.P.; Klein E.A.

Predictors of preferences and utilities in men treated with 3D-CRT for prostate cancer
pp. 34-42(9)
Authors: Watkins Bruner D.; Hanlon A.; Mazzoni S.; Raysor S.; Konski A.; Hanks G.; Pollack A.

Short-term androgen deprivation and PSA doubling time: their association and relationship to disease progression after radiation therapy for prostate cancer
pp. 43-52(10)
Authors: Hanlon A.L.; Horwitz E.M.; Hanks G.E.; Pollack A.

The role of hemoglobin concentration in clinically localized prostate cancer treated with radical radiotherapy +/- neoadjuvant androgen deprivation
pp. 53-58(6)
Authors: Parker C.; Warde P.; Norman A.; Panzarella T.; Catton C.; Horwich A.; Huddart R.; Dearnaley D.

Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy
pp. 59-67(9)
Authors: Liu M.; Pickles T.; Agranovich A.; Berthelet E.; Duncan G.; Keyes M.; Kwan W.; McKenzie M.; Morris J.; Pai H.; Tyldesley S.; Wu J.

Influence of hormonal therapy on late rectal function after permanent prostate brachytherapy with or without supplemental external beam radiotherapy
pp. 68-74(7)
Authors: Merrick G.S.; Butler W.M.; Wallner K.E.; Murray B.C.; Allen Z.; Galbreath R.W.

Spontaneous improvement in late rectal mucosal changes after radiotherapy for prostate cancer
pp. 75-80(6)
Authors: O'Brien P.C.; Hamilton C.S.; Denham J.W.; Gourlay R.; Franklin C.I.V.

Effect of transurethral resection on urinary quality of life after permanent prostate brachytherapy
pp. 81-88(8)
Authors: Merrick G.S.; Butler W.M.; Wallner K.E.; Galbreath R.W.

Evaluation of therapeutic potential of heavy ion therapy for patients with locally advanced prostate cancer
pp. 89-97(9)
Authors: Nikoghosyan A.; Schulz-Ertner D.; Didinger B.; Jakel O.; Zuna I.; Hoss A.; Wannenmacher M.; Debus J.

Rectal bleeding and its management after irradiation for uterine cervical cancer
pp. 98-105(8)
Authors: Chun M.; Kang S.; Kil H.-J.; Oh Y.-T.; Sohn J.-H.; Ryu H.-S.

High-dose-rate intraoperative radiotherapy for close or positive margins in patients with locally advanced or recurrent rectal cancer
pp. 106-112(7)
Authors: Nuyttens J.J.; Kolkman-Deurloo I.-K.K.; Vermaas M.; Ferenschild F.T.; Graveland W.J.; De Wilt J.H.; Hanssens P.E.; Levendag P.C.

Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery
pp. 113-123(11)
Authors: Levendag P.; Braaksma M.; Coche E.; van Der Est H.; Hamoir M.; Muller K.; Noever I.; Nowak P.; van Sorensen De Koste J.; Gregoire V.

Level II lymph nodes and radiation-induced xerostomia
pp. 124-131(8)
Authors: Astreinidou E.; Dehnad H.; Terhaard C.H.J.; Raaijmakers C.P.J.

Location of cervical lymph node metastases in oropharyngeal and hypopharyngeal carcinoma: implications for cranial border of elective nodal target volumes
pp. 132-138(7)
Authors: Prins-Braam P.M.; Raaijmakers C.P.J.; Terhaard C.H.J.

Lymph node metastasis of early oral tongue cancer after interstitial radiotherapy
pp. 139-146(8)
Authors: Yamazaki H.; Inoue T.; Yoshida K.; Tanaka E.; Yoshioka Y.; Nakamura H.; Furukawa S.; Shimizutani K.; Kakimoto N.; Inoue T.

Treatment planning comparison of conventional, 3D conformal, and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma
pp. 147-154(8)
Authors: Mock U.; Georg D.; Bogner J.; Auberger T.; Potter R.

Intraoperative high-dose-rate brachytherapy for paranasal sinus tumors
pp. 155-160(6)
Authors: Nag S.; Tippin D.; Grecula J.; Schuller D.

Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial
pp. 161-166(6)
Authors: Calais G.; Bardet E.; Sire C.; Alfonsi M.; Bourhis J.; Rhein B.; Tortochaux J.; Man Y.T.K.; Auvray H.; Garaud P.

Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study
pp. 167-174(8)
Authors: Ertekin M.V.; Koc M.; Karslioglu I.; Sezen O.

Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy
pp. 175-184(10)
Authors: Munter M.W.; Karger C.P.; Hoffner S.G.; Hof H.; Thilmann C.; Rudat V.; Nill S.; Wannenmacher M.; Debus J.

Loss of cervical spinal curvature during radiotherapy for head-and-neck cancers: the neck moves, too
pp. 185-188(4)
Authors: Garg M.K.; Yaparpalvi R.; Beitler J.J.

Nasopharyngeal carcinoma in children: ten years' experience at the Tata Memorial Hospital, Mumbai
pp. 189-195(7)
Authors: Laskar S.; Sanghavi V.; Muckaden M.A.; Ghosh Laskar S.; Bhalla V.; Banavali S.; Kurkure P.; Nair C.; Dinshaw K.A.

Comparison of the efficacy and acute toxicity of weekly versus daily chemoradiotherapy for non-small-cell lung cancer: a meta-analysis
pp. 196-203(8)
Authors: Rakovitch E.; Tsao M.; Ung Y.; Pignol J.-P.; Cheung P.; Chow E.

Equivalent outcome of patients with clinical Stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection
pp. 204-212(9)
Authors: Taylor N.A.; Liao Z.X.; Cox J.D.; Stevens C.; Roth J.; Walsh G.; Chang J.Y.; Guerrero T.; Jeter M.; Putnam J.; Fossella F.V.; Allen P.; Komaki R.

Pentoxifylline in prevention of radiation-induced lung toxicity in patients with breast and lung cancer: a double-blind randomized trial
pp. 213-219(7)
Authors: Ozturk B.; Egehan I.; Atavci S.; Kitapci M.

Optimization of MammoSite therapy
pp. 220-232(13)
Authors: Astrahan M.A.; Jozsef G.; Streeter O.E.

Fifteen-year results of breast-conserving surgery and definitive irradiation for Stage I and II breast carcinoma: the University of Pennsylvania experience
pp. 233-240(8)
Authors: Santiago R.J.; Wu L.; Harris E.; Fox K.; Schultz D.; Glick J.; Solin L.J.

Randomized, paired comparison of No-Sting Barrier Film versus sorbolene cream (10% glycerine) skin care during postmastectomy irradiation
pp. 241-246(6)
Authors: Graham P.; Browne L.; Capp A.; Fox C.; Graham J.; Hollis J.; Nasser E.

The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial
pp. 247-252(6)
Authors: Sultanem K.; Patrocinio H.; Lambert C.; Corns R.; Leblanc R.; Parker W.; Shenouda G.; Souhami L.

Results of whole brain radiotherapy and recursive partitioning analysis in patients with brain metastases from renal cell carcinoma: a retrospective study
pp. 253-258(6)
Authors: Cannady S.B.; Cavanaugh K.A.; Lee S.-Y.; Bukowski R.M.; Olencki T.E.; Stevens G.H.J.; Barnett G.H.; Suh J.H.

Late neointimal tissue growth behind the stent after intravascular -radiation
pp. 259-266(8)
Authors: Busseuil D.; Zeller M.; Cottin Y.; Maingon P.; Barillot I.; Allouch P.; Ponnelle T.; Bril A.; Briot F.; Wolf J.-E.; Rochette L.

Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors
pp. 267-277(11)
Authors: Barth R.F.; Grecula J.C.; Yang W.; Rotaru J.H.; Nawrocky M.; Gupta N.; Albertson B.J.; Ferketich A.K.; Moeschberger M.L.; Coderre J.A.; Rofstad E.K.

A biplane angiographic study on cardiac motion of coronary artery stents: options to minimize the target volume for high-precision external beam radiotherapy of coronary artery in-stent restenosis
pp. 278-283(6)
Authors: Leter E.M.; Schuurbiers J.C.H.; Nowak P.J.C.M.; Levendag P.C.; Wentzel J.J.; Pattynama P.M.T.; de Feyter P.J.; Serruys P.W.; Slager C.J.

A modified relocatable stereotactic frame for irradiation of eye melanoma: design and evaluation of treatment accuracy
pp. 284-291(8)
Authors: Muller K.; Nowak P.J.C.M.; Luyten G.P.M.; Marijnissen J.P.; de Pan C.; Levendag P.

Influence of prostate volume on dosimetry results in real-time ¹²⁵I seed implantation
pp. 292-299(8)
Authors: McNeely L.K.; Stone N.N.; Presser J.; Chircus J.H.; Stock R.G.